“Chimeric Antigen Receptor T-Cell Manufacturing Turnaround: Vein-to-Vein Time as a Clinical Variable”, TMTJ, vol. 2, no. 1, pp. 1–9, Jan. 2023, doi: 10.5281/zenodo.22649019.